This Cannabis Stock Has Plummeted 80%: Buy It Cheap Now?

The legal pot sector does not present a pretty picture for investors, but there’s room for optimism because of stocks like HEXO Corporation. Let’s take a look.

| More on:
question marks written reminders tickets

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

If you have had anything to do with the legal cannabis sector on the Toronto Stock Exchange or have even the slightest interest in it, you know that the industry is getting crushed right now.

Early investors in the industry gained a lot over the past few years, and the prior year has obliterated any hopes that investors had from the sector.

An industry-wide decline weighed down with scandals, performance issues, regulatory restrictions, and stiff competition from the illegal pot industry has left cannabis producers and investors reeling.

Some people, like yours truly, still believe there are reasons to be hopeful about the long-term prospects of the cannabis sector.

Most analysts expect the global market for marijuana to exceed $100 billion in sales in the next ten years. Others believe the sales could even exceed $200 billion by 2030.

If that’s true, the horrendous downturn could present investors a one-in-a-million chance to scoop up stocks before they grow too far out of their reach.

Make no mistake: I think investing in marijuana stocks would be a contrarian move. Still, I feel that stocks like HEXO Corp (TSX:HEXO)(NYSE:HEXO) can present you likely reasons for optimism in such difficult times for the industry.

A pot company with a unique approach

The $719 million market capitalization company is a minnow. Very few investors are even looking at the company, and a lot of top analysts have shrugged HEXO aside.

HEXO has a unique approach in catering to the burgeoning and struggling legal pot industry, and it could become one of the landmark businesses in the industry. You therefore shouldn’t ignore it.

One of the things that can kill the growth prospects of a company is that the goods it sells become commoditized. Commoditization can effectively allow a business to make profits from the products it sells. Cannabis is a commoditized product now.

HEXO is ahead of the curve in understanding the pitfalls of commoditization, which is why the company has kept commoditized cannabis as a small part of its business. The real money for HEXO lies in creating something that its peers cannot compete with: a cannabis platform.

HEXO does not plan to become just some seller of cannabis. The company is establishing growing facilities, R&D centres and improving its packaging abilities to create the first cannabis platform in the industry.

The company wants to cater to all cannabis-derived consumer goods. They want the end consumer to get access to safe, effective, and compliant cannabis products.

HEXO is partnering with existing brands to take advantage of each company’s expertise in creating a broader customer base. Perhaps one of the most relevant partnerships for the pot producer is with Molson Coors Canada in 2018. HEXO joined hands with the company to produce cannabis-infused beverages.

In the coming year, HEXO wants to expand further with partners to produce sleep aids, edibles, cosmetics, and much more.

Foolish takeaway

At the time of writing, HEXO stocks are trading at $2.64 per share at writing – almost a fifth of its high of $11.11 back in April 2019. 2020 could be the make-or-break year for the company to launch products into the market for successful sales.

The illegal pot industry has beaten up the legal sector. HEXO could be the company that leads the charge for the regulated market to succeed through products that the illegal sector cannot replicate.

While I would not place all my faith in the cannabis sector, HEXO does present investors interested in marijuana a bit of much-needed optimism.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool owns shares of Molson Coors Brewing. The Motley Fool recommends HEXO. and HEXO.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »